Review




Structured Review

Spring Bioscience primary monoclonal antibodies against cd4 sp35
Primary Monoclonal Antibodies Against Cd4 Sp35, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary monoclonal antibodies against cd4 sp35/product/Spring Bioscience
Average 90 stars, based on 1 article reviews
primary monoclonal antibodies against cd4 sp35 - by Bioz Stars, 2026-05
90/100 stars

Images



Similar Products

90
Spring Bioscience primary monoclonal antibodies against cd4 sp35
Primary Monoclonal Antibodies Against Cd4 Sp35, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary monoclonal antibodies against cd4 sp35/product/Spring Bioscience
Average 90 stars, based on 1 article reviews
primary monoclonal antibodies against cd4 sp35 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Cell Marque primary mouse monoclonal antibodies against cd4 sp35
Representative micrographs show low and high <t>CD4,</t> CD8, and Foxp3 positive tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas. Original magnification: 400×
Primary Mouse Monoclonal Antibodies Against Cd4 Sp35, supplied by Cell Marque, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary mouse monoclonal antibodies against cd4 sp35/product/Cell Marque
Average 90 stars, based on 1 article reviews
primary mouse monoclonal antibodies against cd4 sp35 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Representative micrographs show low and high CD4, CD8, and Foxp3 positive tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas. Original magnification: 400×

Journal: Pancreas

Article Title: Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy

doi: 10.1097/MPA.0000000000000914

Figure Lengend Snippet: Representative micrographs show low and high CD4, CD8, and Foxp3 positive tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas. Original magnification: 400×

Article Snippet: Immunohistochemical Analysis for CD4, CD8, FOXP3 Immunohistochemistry for CD4, CD8, and FOXP3 were performed on 4-μm unstained sections from the tissue microarray blocks using primary mouse monoclonal antibodies against CD4 (1:25 dilution, SP35; Cell Marque, Rocklin, Calif), CD8 (1:20 dilution from predilute, C8/144B; Thermo Scientific, Fremont, Calif), and FOXP3 (1:50 dilution, clone 206D, BioLegend, San Diego, Calif).

Techniques:

Clinicopathological Correlations of  CD4,  CD8, and Foxp3 Positive Lymphocytes in PDAC Patients Treated With Neoadjuvant Chemotherapy and Pancreaticoduodenectomy

Journal: Pancreas

Article Title: Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy

doi: 10.1097/MPA.0000000000000914

Figure Lengend Snippet: Clinicopathological Correlations of CD4, CD8, and Foxp3 Positive Lymphocytes in PDAC Patients Treated With Neoadjuvant Chemotherapy and Pancreaticoduodenectomy

Article Snippet: Immunohistochemical Analysis for CD4, CD8, FOXP3 Immunohistochemistry for CD4, CD8, and FOXP3 were performed on 4-μm unstained sections from the tissue microarray blocks using primary mouse monoclonal antibodies against CD4 (1:25 dilution, SP35; Cell Marque, Rocklin, Calif), CD8 (1:20 dilution from predilute, C8/144B; Thermo Scientific, Fremont, Calif), and FOXP3 (1:50 dilution, clone 206D, BioLegend, San Diego, Calif).

Techniques:

Kaplan-Meier curves for disease-free survival (A) and overall survival (B) stratified by CD4+ tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas after treated with neoadjuvant chemoradiation followed by pancreaticoduodenectomy.

Journal: Pancreas

Article Title: Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy

doi: 10.1097/MPA.0000000000000914

Figure Lengend Snippet: Kaplan-Meier curves for disease-free survival (A) and overall survival (B) stratified by CD4+ tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas after treated with neoadjuvant chemoradiation followed by pancreaticoduodenectomy.

Article Snippet: Immunohistochemical Analysis for CD4, CD8, FOXP3 Immunohistochemistry for CD4, CD8, and FOXP3 were performed on 4-μm unstained sections from the tissue microarray blocks using primary mouse monoclonal antibodies against CD4 (1:25 dilution, SP35; Cell Marque, Rocklin, Calif), CD8 (1:20 dilution from predilute, C8/144B; Thermo Scientific, Fremont, Calif), and FOXP3 (1:50 dilution, clone 206D, BioLegend, San Diego, Calif).

Techniques:

Univariate Cox Regression Analysis of Disease-free and Overall Survival in Relation to Clinicopathologic Features

Journal: Pancreas

Article Title: Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy

doi: 10.1097/MPA.0000000000000914

Figure Lengend Snippet: Univariate Cox Regression Analysis of Disease-free and Overall Survival in Relation to Clinicopathologic Features

Article Snippet: Immunohistochemical Analysis for CD4, CD8, FOXP3 Immunohistochemistry for CD4, CD8, and FOXP3 were performed on 4-μm unstained sections from the tissue microarray blocks using primary mouse monoclonal antibodies against CD4 (1:25 dilution, SP35; Cell Marque, Rocklin, Calif), CD8 (1:20 dilution from predilute, C8/144B; Thermo Scientific, Fremont, Calif), and FOXP3 (1:50 dilution, clone 206D, BioLegend, San Diego, Calif).

Techniques:

Multivariate Cox Regression Analysis of Disease-Free and Overall Survival in Relation to Clinicopathologic Features

Journal: Pancreas

Article Title: Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy

doi: 10.1097/MPA.0000000000000914

Figure Lengend Snippet: Multivariate Cox Regression Analysis of Disease-Free and Overall Survival in Relation to Clinicopathologic Features

Article Snippet: Immunohistochemical Analysis for CD4, CD8, FOXP3 Immunohistochemistry for CD4, CD8, and FOXP3 were performed on 4-μm unstained sections from the tissue microarray blocks using primary mouse monoclonal antibodies against CD4 (1:25 dilution, SP35; Cell Marque, Rocklin, Calif), CD8 (1:20 dilution from predilute, C8/144B; Thermo Scientific, Fremont, Calif), and FOXP3 (1:50 dilution, clone 206D, BioLegend, San Diego, Calif).

Techniques: